|
Latest articles: Exelixis files investigational new drug application for anticancer compound
Exelixis, Inc. announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small molecule inhibitor of HSP90, which is a chaperone protein that promotes the activity and stability
Exelixis files investigational new drug application for anticancer compound... Scientists identify a molecule that coordinates the movement of cells
Even cells commute. To get from their birthplace to their work site, they sequentially attach to and detach from an elaborate track of exceptionally strong proteins known as the extracellular matrix. Now, in research to appear in the October 3 issue of Cell, scientists at Rockefeller University show
Scientists identify a molecule that coordinates the movement of cells... Statin-induced muscle disorders are focus of $2.5 million in grants from NIH
Approximately 200,000 of the 38 million people in the U.S. who take statins to treat high cholesterol may develop life-threatening muscle disease.
Statin-induced muscle disorders are focus of $2.5 million in grants from NIH... Vitamin C supplements appear to undercut the effectiveness of cancer drugs
A new study by scientists in the United States has revealed that vitamin C may blunt the effectiveness of chemotherapy treatment.
Vitamin C supplements appear to undercut the effectiveness of cancer drugs... CMS Funds State Efforts To Increase Awareness Of Home-Based Alternatives To Institutional Care
Seven states will receive a share of over $8 million in federal grants to increase awareness of home- and community-based long-term care options for people leaving hospitals who otherwise may enter a traditional nursing home, CMS Acting Administrator Kerry Weems announced. The $8.
More: continued here
CMS Funds State Efforts To Increase Awareness Of Home-Based Alternatives To Institutional Care... NHS Constitution - A Workshop For People Living With Diabetes
The proposed NHS Constitution will affect all of us and it is vital that people living with diabetes have their say. The Constitution will shape the future of the NHS and we need you to get involved. Workshop for people affected by diabetes 8 October
NHS Constitution - A Workshop For People Living With Diabetes... Molecule provides new understanding of cause of colon cancer
Scientists investigating a molecule known to play a key role in causing colon cancer have made a series of ground-breaking discoveries that could have major implications for future treatment of the disease, responsible for 655,000 deaths worldwide per year. Their findings are published in the journal Cancer
Molecule provides new understanding of cause of colon cancer... In Crohn’s Disease A Case Of False Positive Octreoscan
Neuroendocrine tumors, such as carcinoid tumors, overexpress somatostatin receptors in their membranes. Octreotide is an analogue whose molecule is a shortened version of somatostatin’s with a high affinity for these receptors. The labelled form of octreotide is able to be imaged in scans (Octreoscan) and, therefore, pathological conditions
In Crohn’s Disease A Case Of False Positive Octreoscan... REAL Coalition Criticizes Homecare Proposal, USA
A coalition of home and community-based providers today strongly criticized a proposal under consideration by Acting Secretary of Labor and Industry Sandi Vito that could require workers who provide in-home care to seniors and individuals with disabilities to join a state-funded registry called the Consumer Workforce Council.
REAL Coalition Criticizes Homecare Proposal, USA... UCB Pharma Withdraws Its Marketing Authorisation Application For Lacosamide Pain UCB Pharma, Europe
The European Medicines Agency (EMEA) has been formally notified by UCB Pharma S.A. of its decision to withdraw the application for a centralised marketing authorisation for the medicine Lacosamide Pain UCB Pharma (lacosamide) film-coated tablets. Lacosamide Pain UCB Pharma was expected to be used
UCB Pharma Withdraws Its Marketing Authorisation Application For Lacosamide Pain UCB Pharma, Europe...
Articles 1..10 of 1093. Page1 | Next > Latest Searches: http cyberoute com demo docs images gurod ahah, http www elettrodata o articoli p, piracetam nurisng responsibilities, http www agv ry data vela http www horde hunte, http www marsbook co d product 2 mumas ohalupa, http www agv ry data media nexa zevela http www horde hunte DEC, http www interkonet eb editor scripts icons D, http www landi sempa ktionen image zafecez iji, Diffuse esophageal spasm, http www heaven house kz templates c se, http www oriolmanya net nautilus phpBB2 language lang english, http www agv ry data media nexa zevela http www horde hunte, http sinzinuri com imsi db pic huv abey, http www fabcraft co zil DeCLARE S CHAR 4000 S, http www fabcraft co uk forum lovuqo zil DeCLARE S CHAR 4000, http www spoddyland co uk scans youneedtoselectaplanettoclaimb. Top Searches...
 Import RSS Updates... |